Tacrolimus combined with corticosteroids effectively improved the outcome of a cohort of patients with immune-mediated necrotising myopathy.

CONCLUSIONS: Early co-administration of tacrolimus with corticosteroid promoted the remission and recovery of patients with IMNM and seemed to be a relatively safe treatment programme for physician managing immune-mediated necrotising myopathy. PMID: 30620290 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30620290?dopt=Abstract

Source: Clinical and Experimental Rheumatology - January 9, 2019 Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research